ESPP Stacked on RSU Concentration: The Hidden Employer-Stock Exposure

A staff engineer at a public enterprise software company ran through her net worth for the first time at age 38. She had $1.4 million in total assets. $980,000 of it was in her employer’s stock: $740,000 from RSUs that had vested and she had not sold, $150,000 from five years of ESPP purchases she had held, plus $90,000 of early unvested RSUs at current prices. Her 401(k) and taxable brokerage totaled $420,000. Employer stock was 70% of net worth.

Her pre-tax compensation, including future RSU vests scheduled at current prices, added another $1.1 million of employer-stock exposure over the next 4 years. Her human capital was also employer-dependent: her future earnings relied on the company staying solvent and her role surviving. Counting future vests and human capital, more than 85% of her wealth trajectory was tied to a single company.

This was not unusual. It is the modal case for senior tech employees who participate in both RSU vesting and ESPP at maximum rates.

This article walks through the combined exposure and the standard diversification playbook.

The stacking mechanic

Three channels feed employer stock:

RSU vesting: schedule-based delivery of shares, taxed at ordinary rates on the vest-date FMV.
ESPP purchases: periodic employee-funded purchases at a 15%+ discount, taxed at ordinary rates on the discount (qualifying or disqualifying).
Direct purchases: less common but some employees buy in the open market with bonus or salary cash.

Each channel individually is small to moderate. Combined over 5-10 years, they produce concentration.

For a staff engineer at a post-IPO public company:

Annual RSU vest: $250,000 at current prices.
Annual ESPP purchase: $21,000 cash, delivering ~$25,000 of stock.
Annual direct buy: occasional, $10,000-$30,000.
Annual employer-stock accumulation if unsold: $280,000-$305,000.

After 5 years without selling, accumulated employer stock (held at cost basis, ignoring appreciation) is $1.4-$1.5 million. Appreciation can double that.

Why employees do not sell

Several forces:

Tax avoidance. Selling triggers capital gain tax; holding defers it.
Confidence in the company. Working there supposedly gives insight; employees expect the stock to rise.
Administrative friction. Selling requires active decision; holding is passive.
Blackout periods. Trading windows limit when sales are possible.
Pride. Employees identify with the company; selling can feel disloyal.

These forces compound. Year after year, the stock piles up. The concentration builds silently.

The exposure math

Employer stock as a percentage of total net worth is the first metric. Standards vary:

Below 10%: normal exposure.
10-25%: elevated, manageable.
25-50%: significant concentration, active monitoring needed.
50-80%: high concentration, active diversification should be underway.
Above 80%: extreme concentration, typical only during first 2-3 years after a major vest event.

The engineer in the opening at 70% is in the “high concentration” zone. Actively diversifying.

Human capital as an add-on: if your future earnings depend on the same employer, your true exposure is higher than the portfolio percentage suggests. For someone with 70% portfolio concentration and a 10-year expected career at the same company, effective total exposure is often 80-85%.

The single-stock risk statistic

The literature on concentrated stock positions is well-established. For single large-cap stocks held over 10-year windows, roughly 40% underperform the market by more than 25%, and 15-20% go to zero or near-zero. For single mid-cap tech stocks, the tail risk is larger; roughly 25-30% experience drawdowns of 50%+ lasting more than 12 months.

The 2022-2023 period showed this vividly. Stocks like Zoom, Peloton, Robinhood, and Twilio saw 60-90% drawdowns from their 2021 peaks. Employees who held through without diversifying saw large wealth losses. Employees who actively sold into strength preserved capital.

The diversification playbook

Standard steps for employees at 50%+ concentration:

Compute your current concentration percentage. Include RSU vests (shares held), ESPP shares held, and direct purchases. Exclude unvested RSUs from immediate risk but track for future exposure.
Set a target concentration percentage. Common targets: 10-20% for long-term hold, 30% for active monitors.
Sell down to target over 12-24 months. Rapid sales trigger capital gain concentration in one tax year. Spreading across years smooths the tax hit.
Reinvest proceeds in broad-market index funds or, for more sophisticated approaches, direct-indexing strategies that harvest tax losses.
Going forward: sell at vest for new RSU grants. Sell at purchase for new ESPP cycles. Default to diversification at every delivery event.
Consider exchange funds, variable prepaid forwards, or collar strategies for very large positions where the tax-deferral value of hedging exceeds the deferral cost.

The “my company is different” trap

Every concentrated employee believes their company is the exception. Sometimes they are right. In aggregate, they are not.

A useful exercise: look at peer companies 5-10 years post-IPO. For every Apple or Microsoft (continued strong performance), there are multiple GoPros, Snaps, Peletons, Blue Aprons, or Box.coms where the stock underperformed the market significantly. The ex-ante probability of being the exception is low.

Diversification does not require bearishness. It requires only admitting that you cannot reliably outperform by concentrating.

ESPP-specific dynamics

The ESPP adds a particular dynamic. The 15% discount rewards purchase but not necessarily holding. The return is captured at purchase regardless of whether the employee holds or sells.

For concentration-sensitive employees, the right move is:

Enroll at max.
Sell at purchase (disqualifying disposition).
Redeploy proceeds into diversified funds.

This captures 17.6%+ returns per purchase period (annualizing to 35%+) without adding to concentration. The tax hit is on ordinary income treatment of the discount, but the after-tax return is still strong.

Employees who hold ESPP shares for qualifying disposition sacrifice the 17.6% discount in exchange for LTCG treatment on appreciation. The benefit is often $500-$1,500 per purchase, not life-changing, and concentration costs can exceed this tax benefit.

RSU-specific dynamics

RSUs deliver shares regardless of choice. The sell-at-vest question is a live one every vesting event. The mechanical answer for concentrated holders: sell the day of vest, before any lockup or blackout interferes.

Tax-wise, the W-2 already reported the vest-date FMV as ordinary income, so basis equals vest price and selling at vest triggers zero capital gain. Net-share-settlement already covered withholding. The post-vest share block can be liquidated with one click. For concentration management, this is the cleanest reduction.

Delaying sale is a bet on the stock. For diversified employees, that bet is fine. For concentrated employees, it compounds the problem.

Exchange funds and hedges

For large positions (typically $500K+ or concentrated well above portfolio target), specialized tools apply:

Exchange funds: pool shares with other concentrated holders to achieve diversification on a tax-deferred basis. Typically 7-year holding period.
Variable prepaid forwards: receive cash now, deliver shares later, with some downside protection.
Collar strategies: buy puts and sell calls around the current price to bound the range.

These tools carry complexity and fees. For most individuals with concentrations under $500K, straight selling and reinvesting is simpler and cheaper.

Frequently asked

How do I compute my true concentration? Sum the market value of all employer shares (vested, held from ESPP, held from direct purchase). Divide by total net worth (including retirement accounts, real estate equity, cash). If the number exceeds 30%, develop a diversification plan.

Does unvested RSU count toward concentration? In the purest sense, no; unvested RSUs are contingent compensation, not current assets. But for risk management, treating 50% of unvested RSU value as current exposure is a reasonable approximation.

What about employer 401(k) match in company stock? Count this too. Some 401(k) plans default match to employer stock. Changing the allocation to index funds is usually allowed and diversifies the retirement-account exposure.

Can I avoid the tax hit on diversification? Partial options: donate appreciated shares to charity (for qualified giving), use exchange funds, or stage sales across tax years. Most reduction comes from accepting some tax in exchange for reduced risk.

Is there a professional service for this? Yes. Several wealth managers specialize in concentrated-position unwinds for tech employees. Standard fee: 0.5-1% of assets under management. For most single-digit-millionaire cases, DIY with index funds is adequate.

Next step

Compute your employer-stock percentage of net worth this month. If it is above 30%, set a 12-month plan to reduce it. Start by redirecting all future RSU vests and ESPP purchases to immediate sale and index-fund reinvestment. That stops the buildup. Next, plan sales of existing holdings across two or three tax years to smooth the capital gain hit. Aim for a final concentration below 20% within 24 months.